Abstract
Myocardial accumulation of In-111-antimyosin (InAM) was evaluated in comparison with circulating serum myosin light chain I (LCI) level at the time of InAM injection. Seventeen consecutive patients were studied at various stages ranging from 6 days to 34 days after myocardial infarction (MI). The infarct area was positive for InAM uptake in all patients (100%), and significant myocardial uptake was observed in 14 patients (82.4%). The intensity of InAM uptake correlated with the infarct location shown by ECG and CAG. In contrast, 12 patients (70.6%) had normal or undetectable serum myosin LCI levels, with 5 being normal (0.42–2.5 ng/ml) and 7 undetectable (0.42 ng/ml or less). Only 5 patients (29.4%) had elevated serum myosin LCI levels at the time of InAM injection, and this elevation was slight, ranging from 3.4 to 4.5 ng/ml (mean: 3.75 ng/ml). Among patients with undetectable, normal, and elevated serum myosin LCI levels, there was no significant correlation between InAM uptake and the serum myosin LCI level. Thus, even after the serum myosin LCI level has decreased to normal, InAM can still bind to cardiac myosin in patients with MI, presumably until there is complete recovery from the hibernating myocardium due to ischemic damage.
Similar content being viewed by others
References
Katus HA, Yasuda T, Gold H, et al: Diagnosis of acute myocardial infarction by detection of circulating cardiac myosin light chains.Am J Cardiol 54: 964–970, 1984
Leger JOC, Bouvagnet P, Pau B, Roncucci R, Leger JJ: Levels of ventricular myosin fragment in human sera after myocardial infarction, determined with monoclonal antibodies to myosin heavy chain.Eur J Clin Invest 15: 422–429, 1985
Isobe M, Nagai R, Ueda S, et al: Quantitative relationship between left ventricular function and serum cardiac myosin light chain I levels after coronary reperfusion.Circulation 76: 1252–1261, 1987
Khaw BA, Gold HK, Yasuda T, et al: Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody.Circulation 74: 501–508, 1986
Johnson LL, Seldin EW, Becker LC, et al: Anti-myosin imaging in acute transmural myocardial infarctions: results of a multicenter clinical trial.JACC 13: 27–35, 1989
Antunes ML, Seldin DW, Wall RM, Johnson LL: Measurement of acute Q wave myocardial infarct size with SPECT imaging of indium-111 antimyosin.Am J Cardiol 63: 777–783, 1989
Kawai C, Matsumori A, Nishimura T, et al:111In-Antimyosin Fab Scintigraphy in Cardiovascular diseases: Multicenter clinical trial.Jpn J Nucl Med 27: 1419–1432, 1990
Tamaki N, Yamada T, Matsumori A, et al: Indium-111-antimyosin antibody imaging for detecting different stages of myocardial infarction: comparison with technetium-99m-pyrophosphate imaging.J Nucl Med 31: 136–142, 1990
Takasu F, Yazaki Y, Nagai R, et al: Development of an immunoradiometric assay kit (Myosin LI kit “Yamasa”) for cardiac myosin light chain I, and its clinical significance in acute myocardial infarction.SAISHIN-IGAKU 44: 1709–1719, 1989
Nagai R, Ueda S, Yasaki Y: Radioimmunoassay of cardiac myosin light chain II in the serum following experimental myocardial infarction.Bioch Biophys Res Commun 86: 683–688, 1979
Fukuchi M, Naruse H, Ishimura J, Kawanaka M, Iwasaki T: Clinical assessment of serum myosin light chain I in the patients with myocardial infarction: a comparison with myocardial imaging with In-111-antimyosin monoclonal antibody [Abstract].J Nucl Med 31: 714, 1990
Khaw BA, Beller GA, Haber E, Smith TW: Localization of cardiac myosin-specific antibody in myocardial infarction.J Clin Invest 58: 439–446, 1976
Khaw BA, Fallon JT, Gole HK, et al: Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab.J Nucl Med 28: 1671–1678, 1987
Khaw BA, Fallon JT, Strauss HW, Haber E: Myocardial infarct imaging of antibodies to canine cardiac myosin with indium-111-diethylenetriamine pentaacetic acid.Science 209: 295–297, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suehiro, M., Fukuchi, M., Naruse, H. et al. Myocardial uptake of antimyosin antibody compared with serum myosin light chain I levels in patients with myocardial infarction. Ann Nucl Med 6, 37–41 (1992). https://doi.org/10.1007/BF03164640
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03164640